Karnataka, India

Bhaskaran Savarimuthu

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cytiva Sweden Ab. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bhaskaran Savarimuthu. Retrieved from https://idiyas.com/inventor/bhaskaran-savarimuthu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bhaskaran Savarimuthu: Innovator in Biotechnology

Introduction

Bhaskaran Savarimuthu is a notable inventor based in Bengaluru, India. He is currently associated with Cytiva Sweden AB, a company that specializes in biotechnology and life sciences. Despite having no patents to his name, his contributions to the field are significant.

Latest Patents

As of now, Bhaskaran Savarimuthu holds 1 patents. This indicates that his work may be more focused on research and development rather than patenting inventions.

Career Highlights

Bhaskaran has built a career in the biotechnology sector, working with Cytiva Sweden AB. His role involves collaborating with other professionals in the field to advance biotechnological innovations.

Collaborations

Some of his coworkers include Hanish Lakhani and Preetam Hosamani. Their collective expertise contributes to the innovative environment at Cytiva Sweden AB.

Conclusion

Bhaskaran Savarimuthu is an influential figure in the biotechnology industry, contributing to advancements through his work at Cytiva Sweden AB. His career reflects a commitment to innovation and collaboration in the life sciences sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…